1. Home
  2. RZLT vs ACTG Comparison

RZLT vs ACTG Comparison

Compare RZLT & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • ACTG
  • Stock Information
  • Founded
  • RZLT 2010
  • ACTG 1993
  • Country
  • RZLT United States
  • ACTG United States
  • Employees
  • RZLT N/A
  • ACTG N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • ACTG Multi-Sector Companies
  • Sector
  • RZLT Health Care
  • ACTG Miscellaneous
  • Exchange
  • RZLT Nasdaq
  • ACTG Nasdaq
  • Market Cap
  • RZLT 361.3M
  • ACTG 362.6M
  • IPO Year
  • RZLT N/A
  • ACTG 1996
  • Fundamental
  • Price
  • RZLT $5.86
  • ACTG $3.59
  • Analyst Decision
  • RZLT Strong Buy
  • ACTG
  • Analyst Count
  • RZLT 6
  • ACTG 0
  • Target Price
  • RZLT $12.00
  • ACTG N/A
  • AVG Volume (30 Days)
  • RZLT 936.0K
  • ACTG 171.0K
  • Earning Date
  • RZLT 09-18-2025
  • ACTG 08-06-2025
  • Dividend Yield
  • RZLT N/A
  • ACTG N/A
  • EPS Growth
  • RZLT N/A
  • ACTG N/A
  • EPS
  • RZLT N/A
  • ACTG N/A
  • Revenue
  • RZLT N/A
  • ACTG $222,414,000.00
  • Revenue This Year
  • RZLT N/A
  • ACTG $141.36
  • Revenue Next Year
  • RZLT N/A
  • ACTG N/A
  • P/E Ratio
  • RZLT N/A
  • ACTG N/A
  • Revenue Growth
  • RZLT N/A
  • ACTG 65.22
  • 52 Week Low
  • RZLT $2.22
  • ACTG $2.70
  • 52 Week High
  • RZLT $6.65
  • ACTG $5.36
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 61.91
  • ACTG 45.37
  • Support Level
  • RZLT $5.71
  • ACTG $3.36
  • Resistance Level
  • RZLT $6.09
  • ACTG $3.88
  • Average True Range (ATR)
  • RZLT 0.33
  • ACTG 0.12
  • MACD
  • RZLT -0.04
  • ACTG -0.03
  • Stochastic Oscillator
  • RZLT 44.91
  • ACTG 44.23

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

About ACTG Acacia Research Corporation (Acacia Tech)

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.

Share on Social Networks: